Company: KROS
Filing Date: 2025-10-15
Form Type: 8-K
Source: 0001104659-25-099512
Chunk: 6

Company: Keros Therapeutics, Inc.
Filing Date: 2025-10-15
Form: 8-K
Item: Item 9.01
Chunk 6
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                               
          2.1      Stock Purchase Agreement, dated as of October 15, 2025, by and between the Company and ADAR1.             
          2.2      Stock Purchase Agreement, dated as of October 15, 2025, by and between the Company and Pontifax.          
         99.1      Press Release, dated October 15, 2025.                                                                    
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)  

   4  

sIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

  KEROS THERAPEUTICS, INC.                               
  By:                           /s/ Jasbir Seehra        
                                Jasbir Seehra, Ph. D.    
                                Chief Executive Officer  

Dated: October 15, 2025

   5